QT

Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings

Retrieved on: 
Tuesday, July 11, 2023
Partnership, Probability, Adial, Virginia, Heavy menstrual bleeding, NDA, ECG, ICH, Research, QT, AUD, Patient, Physician, Risk, MA, FDA, Safety, Pharmaceutical industry, Dietary supplement, EU

Reviewed the safety data from the ONWARD trial and did not express any concerns with the data.

Key Points: 
  • Reviewed the safety data from the ONWARD trial and did not express any concerns with the data.
  • Confirmation of the importance of identifying a patient subgroup where a relevant treatment effect and compelling evidence of a favorable risk-benefit profile can be assessed.
  • The new clinical development plan includes both the US and EU endpoints and will be designed to satisfy both US and EU AD04 submission requirements.
  • Confirmation of the clinical development plan and pathway is currently being conducted by Adial’s clinical development and regulatory advisors.

Save Big on SetPower Portable Fridges for Prime Day

Retrieved on: 
Friday, July 7, 2023
Giant, RV, Food, QT, CITY, FC, Temperature, X50, Compaq tc series, TC, Heating, ventilation, and air conditioning, Video game

As a company that manufactures and provides high quality portable fridge freezers designed to fit the outdoor lifestyle.

Key Points: 
  • As a company that manufactures and provides high quality portable fridge freezers designed to fit the outdoor lifestyle.
  • SetPower is thrilled to announce exclusive offers on its official website during the Prime Day promotion.
  • From July 10th to July 13th, all outdoor enthusiasts can take advantage of the Prime Day special promotion, enjoy significant benefits, and gain access to innovative and durable portable fridges designed to enhance outdoor experiences.
  • This Prime Day promotion presents a prime opportunity for customers to experience the benefits of SetPower fridges and elevate their outdoor fun to new heights.

Helios Technologies Introduces OpenPV™

Retrieved on: 
Wednesday, July 5, 2023
Other Manufacturing, Technology, Automotive, General Automotive, Engineering, Automotive Manufacturing, Manufacturing, Software, Electronic Design Automation, Innovative Satellite Technology Demonstration Program, HP OpenView, UI, Senior, Microsoft Windows, QT, Electronics, Innovation, Multimedia, NYSE, Linux, Ubuntu, Mobile phone, Video game, Mac

Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, is proud to announce the launch of its newest software product, OpenPV™ , a sophisticated set of tools that empowers software developers to create complex applications for rugged OpenView ™ displays offered by Enovation Controls , part of Helios’ Electronics segment.

Key Points: 
  • Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, is proud to announce the launch of its newest software product, OpenPV™ , a sophisticated set of tools that empowers software developers to create complex applications for rugged OpenView ™ displays offered by Enovation Controls , part of Helios’ Electronics segment.
  • “We anticipate the launch of OpenPV™ to bring significant benefits to our customers, specifically in the construction, material handling, and stationary equipment markets initially.
  • Currently, the platform is compatible with Windows and Linux Ubuntu development environments; Mac support will be added in the future.
  • This platform offers experienced developers the freedom to design and implement their tailored applications using their preferred tools and contemporary programming languages.”

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

Retrieved on: 
Thursday, June 29, 2023
CLL, Hypersensitivity, Lymphocytosis, Pimozide, Arrhythmia, Tacrolimus, Chronic lymphocytic leukemia, SLL, Liver disease, Simvastatin, Magnesium, Atorvastatin, Antifungal, Person, QT, Sirolimus, QT interval, Ergot, Alkaline phosphatase, Plasma, Kidney, Lovastatin, Ergotism, Patient, Azole, Risk, Electrolyte, Ergotamine, Dihydroergotamine, Tumor lysis syndrome, Ciclosporin, ALT, Quinidine, Rhabdomyolysis, Potassium, AST, Venetoclax, Pharmaceutical industry, Posaconazole, CYP3A4

Concomitant administration of posaconazole with sirolimus increases the sirolimus blood concentrations by approximately 9-fold and can result in sirolimus toxicity.

Key Points: 
  • Concomitant administration of posaconazole with sirolimus increases the sirolimus blood concentrations by approximately 9-fold and can result in sirolimus toxicity.
  • Posaconazole may increase the plasma concentrations of ergot alkaloids (ergotamine and dihydroergotamine) which may lead to ergotism.
  • Reserve azole antifungals, including posaconazole injection, for patients receiving a vinca alkaloid, including vincristine, who have no alternative antifungal treatment options.
  • Posaconazole injection is indicated for the treatment of invasive aspergillosis in adults and pediatric patients 13 years of age and older.

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

Retrieved on: 
Thursday, June 29, 2023
CLL, Hypersensitivity, Lymphocytosis, Pimozide, Arrhythmia, Tacrolimus, Chronic lymphocytic leukemia, SLL, Liver disease, Simvastatin, Magnesium, Atorvastatin, Antifungal, Person, QT, Sirolimus, QT interval, Ergot, Alkaline phosphatase, Plasma, Kidney, Lovastatin, Ergotism, Patient, Azole, Risk, Electrolyte, Ergotamine, Dihydroergotamine, Tumor lysis syndrome, Ciclosporin, ALT, Quinidine, Rhabdomyolysis, Potassium, AST, Venetoclax, Pharmaceutical industry, Posaconazole, CYP3A4

Concomitant administration of posaconazole with sirolimus increases the sirolimus blood concentrations by approximately 9-fold and can result in sirolimus toxicity.

Key Points: 
  • Concomitant administration of posaconazole with sirolimus increases the sirolimus blood concentrations by approximately 9-fold and can result in sirolimus toxicity.
  • Posaconazole may increase the plasma concentrations of ergot alkaloids (ergotamine and dihydroergotamine) which may lead to ergotism.
  • Reserve azole antifungals, including posaconazole injection, for patients receiving a vinca alkaloid, including vincristine, who have no alternative antifungal treatment options.
  • Posaconazole injection is indicated for the treatment of invasive aspergillosis in adults and pediatric patients 13 years of age and older.

Dr. Susan Love Foundation for Breast Cancer Research and QT Imaging Embark on the Second Phase of 3D Breast Imaging Research Study

Retrieved on: 
Monday, June 26, 2023
Breast Cancer Research, Radiation, Public, Anatomy, Breast cancer, Breast, Woman, Cryotherapy, Research, QT, Radiology, MRI, AIDS, DSM-IV codes, IRB, Risk, Map, Patient, Collection, Menstrual cycle, FGV, Diagnosis, Mortality, FDA, BMI, Breast duct endoscopy, Disease, Birth control, Medical imaging

This critical next-stage research will illuminate previously unmapped anatomy crucial to combating breast cancer.

Key Points: 
  • This critical next-stage research will illuminate previously unmapped anatomy crucial to combating breast cancer.
  • Nearly 80 percent of all breast cancers are believed to begin in the lining of the breast ducts.
  • The DRSLF research has also developed the first 3D printing of the anatomy of the human breast.
  • Says Klock, "Innovation is nothing new for QT Imaging®, and partnering with the Foundation in this next phase is simply another way to advance treatment in breast cancer care."

TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial

Retrieved on: 
Sunday, June 4, 2023
Biotechnology, Pharmaceutical, Health, Oncology, LVEF, Electrolyte, Cardiomyopathy, Fever, QT interval, Periodic breathing, ILD, Grade, Wireless ambulatory ECG, Patient, Heart, Safety, QT, Cough, Pharmaceutical industry

At the previously reported disease-free survival analysis, all patients had completed or discontinued treatment.

Key Points: 
  • At the previously reported disease-free survival analysis, all patients had completed or discontinued treatment.
  • Interstitial lung disease (ILD)/pneumonitis occurred in 3.7% of the 1479 TAGRISSO-treated patients; 0.3% of cases were fatal.
  • Permanently discontinue TAGRISSO if ILD is confirmed
    Heart rate-corrected QT (QTc) interval prolongation occurs in TAGRISSO-treated patients.
  • In the ADAURA study, 1.5% (5/325) of TAGRISSO-treated patients experienced LVEF decreases ≥10% from baseline and a drop to

NEW OVAL AU GRATIN AND NEW SQUARE GRILL PAN JOIN THE AWARD-WINNING KITCHENAID® ENAMELED CAST IRON COLLECTION

Retrieved on: 
Thursday, June 1, 2023
Pistachio, Meyer Corporation, QT, KitchenAid, Sears, Cast iron, Frying pan, Iron, Grill pan, Baking

VALLEJO, Calif., June 1, 2023 /PRNewswire/ -- Following last summer's successful launch of its colorful, high-quality KitchenAid® Enameled Cast Iron cookware collection, Meyer Corporation, U.S. announces the addition of two new specialty items – the KitchenAid® Enameled Cast Iron 2.5 Qt.

Key Points: 
  • VALLEJO, Calif., June 1, 2023 /PRNewswire/ -- Following last summer's successful launch of its colorful, high-quality KitchenAid® Enameled Cast Iron cookware collection, Meyer Corporation, U.S. announces the addition of two new specialty items – the KitchenAid® Enameled Cast Iron 2.5 Qt.
  • Oval au Gratin , and the KitchenAid® Enameled Cast Iron 11 inch Square Grill Pan .
  • Oval au Gratin and 11 inch Square Grill Pan feature the same contemporary look and on-trend hues.
  • Crafted with two small side handles, the Grill Pan transitions easily from stovetop to oven or broiler.

NEW KITCHENAID® HARD-ANODIZED CERAMIC COOKWARE

Retrieved on: 
Wednesday, May 31, 2023
Partnership, PFAS, Meyer Corporation, QT, Lead, Cookware and bakeware, Ceramic, KitchenAid, Collection, Cooking, PTFE, BPA, Stock pot, Cadmium, Pistachio

Providing home cooks with the ultimate in convenience and versatility, KitchenAid Hard-Anodized Ceramic features a long-lasting ceramic nonstick cooking surface crafted without PFAS, BPA, lead, or cadmium. The easy-clean ceramic nonstick ensures even the stickiest foods release effortlessly, and that cleanup is quick. The nonstick is styled in a unique "milkshake" color, which beautifully complements the high-heat exterior finish of Pistachio and Blue Velvet -- two soft hues that can also be found in the recently launched, award-winning collection of KitchenAid Enameled Cast Iron Cookware.

Key Points: 
  • For those seeking an alternative to traditional PTFE nonstick, and desire cookware that's made for everyday cooking and beautiful kitchen-to-table presentations, KitchenAid Hard-Anodized Ceramic Cookware perfectly fuses optimum performance with pleasing design.
  • Providing home cooks with the ultimate in convenience and versatility, KitchenAid Hard-Anodized Ceramic features a long-lasting ceramic nonstick cooking surface crafted without PFAS, BPA, lead, or cadmium.
  • The easy-clean ceramic nonstick ensures even the stickiest foods release effortlessly, and that cleanup is quick.
  • KitchenAid Hard-Anodized Ceramic is offered in the following sets and open stock items:
    10-Piece Set: 1.5 Qt.

Hesai Technology and CRATUS Technology Announce Strategic Partnership to Develop Autonomous Warehouse Solutions Using Safety Rated 3D Lidar

Retrieved on: 
Monday, May 22, 2023
Raketenjagdpanzer 1, Senior, PALO, ISO, AGV, Perception, 3D, Amr El Abbadi, Light, AMR, 's-Hertogenbosch, QT, 2D, Certification, Sunlight, FOV, Safety, Global Sales Law Project, Surveying

PALO ALTO, Calif., May 22, 2023 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), a global leader in lidar solutions, and CRATUS, a software solution integrator for lidar systems, today announced a strategic alliance to develop autonomous warehouse solutions using Hesai's groundbreaking safety-rated 3D lidar, the QT128.

Key Points: 
  • PALO ALTO, Calif., May 22, 2023 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), a global leader in lidar solutions, and CRATUS, a software solution integrator for lidar systems, today announced a strategic alliance to develop autonomous warehouse solutions using Hesai's groundbreaking safety-rated 3D lidar, the QT128.
  • Hesai's safety rated QT model, with 128 laser channels, enables a multitude of new features for AGVs and autonomous forklifts.
  • CRATUS and Hesai will work together to release a series of drivers, middleware, and end solutions centered around the QT128 lidar sensor.
  • These solutions will hasten the adoption rate of 3D lidar within the material handling sector and unlock new possibilities for robotic applications within the warehouse.